Epigenetics Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4244
Epigenetics Market size is projected to experience significant growth from 2019 to 2025.
Increase in number of people suffering from chronic diseases will boost the epigenetics market growth in the near future. According to World Health Organization (WHO), chronic diseases account for an estimated 35 million deaths per year, that accounts for around 60% of world mortality. Increasing use of epigenetic based treatments to treat chronic diseases having more immediate and practical effect will lead to significant industry growth in the future.
Recent technological advancements involving epigenetics will propel market growth. Developments in DNA methylation technology have made it possible for researchers and scientists to understand the tools that are important for the epigenetic research. These new technologies offer lucrative growth opportunities that will result in industry expansion over the forecast period.
However, high cost of devices that are needed for epigenetics research will be one of the major growth impeding factors. High cost involving the complete procedure and equipments such as MethyLight assay, used in TaqMan fluorescence-based, real-time PCR method is most likely to restrain industry proliferation.
Enzymes segment is expected to show lucrative growth in the upcoming years. High growth is attributed to rising demand for enzymes due to various advantages associated with them. There are many enzymes that are used to catalyze epigenetic modifications and are critical for enzymatic complexes, resulting in increasing study of proteins in diverse pathological and normal procedures. Aforementioned factors will be responsible for generating immense segmental revenue in upcoming years.
Rising application of epigenetics for treatment of cardiovascular diseases is one of the major growth rendering factor. Cardiovascular disease is one of the leading cause of death across the world. For instance, as per the American Heart Association estimates, in 2016 about 121.5 million Americans were affected by cardiovascular diseases. In the past few years, epigenetics led to development of various genetic therapies capable of providing novel treatment approach for various idiopathic disorders.
DNA methylation technology is expected to show robust growth in the future owing to its epigenetic memory of specific cells, high stability and regulation of activity and expression of histone codes. A number of studies have shown that DNA methylation is superior epigenetic agent that can influence the development of chromatin modifications and durability, development of mutations and gene expressions, thus leading to segmental growth.
U.S. is expected to hold majority of the market share in the forthcoming years. Increase in the number of people suffering for chronic diseases such as cancer, diabetes and cardiovascular diseases will boost industry growth. According to a new study by American Heart Association, around 48% of Americans were diagnosed with cardiovascular diseases in 2016. Rising prevalence of chronic disease will favor the growth of epigenetics in the U.S.
China is estimated to show substantial growth in the coming years. In China, chronic diseases are anticipated to account for almost 80% of all the deaths. According to World Health Organization (WHO) estimates, more that 80 million people will suffer from chronic diseases by 2025 in China. Rising cases of chronic diseases, improving healthcare infrastructure, increasing government initiatives and funding for R&D activities will boost the Chinese epigenetics market in the future.
Some of the key industry players Thermo Fisher, llumina, Qiagen, Diagenode, Merck, Abcam, Active Motif, Agilent, Zymo Research, PerkinElmer and Bio-Rad. The companies are focusing on increasing investments in R&D activities along with new product launches to expand their business and product portfolio.
Epigenetics Market, by Product, 2014-2025 (USD Million)
- Instruments and Consumables
- Bioinformatic tools
Epigenetics Market, by Application, 2014-2025 (USD Million)
- Cardiovascular diseases
- Developmental biology
Epigenetics Market, by Technology, 2014-2025 (USD Million)
- Histone Modification
- DNA Methylation
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Thermo Fisher
- Merck Millipore
- Active Motif
- New England Biolabs
- Zymo Research
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.